AI Science Tracker
EN

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Inonu University, Malatya 44280, Turkey.

1 discovery from 2023

Discoveries

Cancer Metastasis Prediction and Genomic Biomarker Identification through Machine Learning and eXplainable Artificial Intelligence in Breast Cancer Research.

Source check: Source checked. Not independent scientific confirmation.

Finding: LightGBM links genomic biomarkers to cancer metastasis prediction. AI role: Elastic net, LightGBM, CatBoost, XGBoost, gradient boosting and AdaBoost. The article appeared in Diagnostics (Basel, Switzerland).

Technology: Elastic net, LightGBM, CatBoost, XGBoost, gradient boosting and AdaBoost

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Elastic net, LightGBM, CatBoost, XGBoost, gradient boosting and AdaBoost
Test and result
LightGBM links genomic biomarkers to cancer metastasis prediction.
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10650093/ · https://pubmed.ncbi.nlm.nih.gov/37958210/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.